Table 1 Characteristics of the individual participants.
Patient ID | S1 | S2 | S3 | S4 | |
|---|---|---|---|---|---|
Age | 49 | 49 | 78 | 80 | |
Date of Stroke* | 25/04/04 | 15/07/04 | 31/01/05 | 03/01/05 | |
Date of Testing* | 28/06/04 | 23/08/04 | 23/02/05 | 15/02/05 | |
Time from stroke to testing (months) | ~2 | ~1 | ~1 | ~1.5 | |
Location of stroke | Left interior capsule | Right pontine lacunar | Left cerebellar | Left lacunar | |
Medication(s) | Atorvastatin Perindopril | Losartan HCTZ Plavix Nifedipine | Diazepam Glycerin Atorvastatin Heparin Sodium ASA | Plavix Rampril HCTZ Cardizem | |
NIHSS** (adm/disch**) | 3/3 | 5/3 | 1/1 | 5/2 | |
CMSA leg score (adm/disch) | 6/6 | 4/5 | 6/6 | 3/4 | |
FIM** (adm/disch) | 100/115 | 61/106 | 74/103 | 88/107 | |
FIM (locomotion; adm/disch) | 6/7 | 5/5 | 4/6 | 2/6 | |
FIM (upper body; adm/disch) | 6/7 | 3/6 | 5/6 | 4/6 | |
Resting HR** (day of testing; bpm) | 79 | 71 | 53 | 62 | |
Lower limit target HR training zone (bpm) | 105 | 101 | 77 | 88 | |
Peak demonstrated HR | 113 | 107 | 97 | 110 | |
Peak demonstrated VO2 (ml/kg/min) | 12.8 | 10.4 | 15.2 | 8.9 | |
Amount of time in each activity category (AC) [10] | |||||
Activity Categories | 0 | 8% | 2% | 26% | 52% |
| Â | 1 | 51% | 21% | 28% | 13% |
| Â | 2 | No samples; see text for explanation | |||
| Â | 3 | 21% | 20% | 24% | 20% |
| Â | 4 | 20% | 57% | 22% | 15% |